bf/NASDAQ:CUE_icon.jpeg

NASDAQ:CUE

Cue Biopharma, Inc.

  • Stock

USD

Last Close

0.72

06/11 21:00

Market Cap

43.11M

Beta: 2.00

Volume Today

48.55K

Avg: 186.50K

PE Ratio

−2.14

PFCF: −2.73

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
112.75K
-
112.75K
0%
7.56M
6,605.10%
7.56M
0%
0.50
-
average payables
664.56K
-
1.68M
153.13%
1.46M
13.27%
1.48M
1.20%
2.33M
57.84%
2.66M
14.18%
3.12M
17.11%
average receivables
426.19K
-
426.19K
0%
377.45K
11.44%
1.09M
187.77%
2.28M
109.91%
1.60M
29.83%
877.63K
45.14%
book value per share
0.34
-
0.74
118.71%
2.98
305.99%
1.69
43.47%
2.48
46.77%
2.75
11.07%
2.09
23.89%
1.84
11.99%
0.81
56.01%
capex per share
-0.04
-
-0.02
31.59%
-0.06
133.53%
-0.09
57.76%
-0.00
97.72%
-0.02
886.66%
-0.03
40.65%
-0.00
83.59%
capex to depreciation
-16.83
-
-2.55
84.83%
-2.87
12.48%
-2.44
15.05%
-0.01
99.63%
-0.56
6,173.14%
0.51
191.23%
-0.09
118.41%
capex to operating cash flow
0.46
-
0.09
81.00%
0.10
14.32%
0.07
28.96%
0.00
97.86%
0.02
1,117.12%
0.02
28.33%
0.00
82.63%
capex to revenue
-1.62
-
-0.01
99.17%
-0.19
1,307.82%
-0.06
67.62%
-0.14
124.39%
cash per share
0.31
-
0.73
132.00%
3.08
324.57%
1.95
36.78%
2.70
38.39%
2.96
9.76%
2.06
30.45%
2.14
4.01%
1.06
50.45%
days of inventory on hand
days payables outstanding
371.90
-
days sales outstanding
79.68
-
164.02
105.85%
76.77
53.20%
16.78
78.14%
112.89
572.70%
debt to assets
0.04
-
0.08
-
0.07
11.30%
0.12
67.89%
0.21
75.55%
0.19
11.42%
debt to equity
0.04
-
0.11
-
0.09
14.71%
0.15
69.50%
0.29
91.58%
0.31
5.75%
dividend yield
earnings yield
-0.01
-
-0.03
297.06%
-0.10
203.38%
-0.41
325.60%
-0.10
74.54%
-0.12
18.98%
-0.12
0.02%
-0.52
316.36%
-0.42
19.18%
enterprise value
233.64M
-
225.12M
3.65%
179.02M
20.48%
73.83M
58.76%
311.42M
321.81%
291.17M
6.50%
299.52M
2.87%
69.30M
76.86%
86.97M
25.50%
enterprise value over ebitda
-124.02
-
-30.19
75.66%
-7.85
74.01%
-1.95
75.20%
-8.47
335.21%
-6.62
21.84%
-6.85
3.51%
-1.37
80.08%
-1.79
31.22%
ev to operating cash flow
-140.96
-
-37.72
73.24%
-14.68
61.07%
-2.80
80.96%
-10.11
261.74%
-8.96
11.38%
-7.71
13.93%
-1.66
78.51%
-2.18
31.29%
ev to sales
64.62
-
90.06
39.38%
92.31
2.50%
20.05
78.28%
55.65
177.62%
15.84
71.53%
free cash flow per share
-0.12
-
-0.31
168.85%
-0.65
106.60%
-1.40
116.30%
-1.40
0.32%
-1.15
17.57%
-1.27
10.16%
-1.18
7.33%
-0.87
25.83%
free cash flow yield
-0.01
-
-0.03
168.85%
-0.06
106.60%
-0.30
435.22%
-0.09
70.49%
-0.09
4.60%
-0.11
21.85%
-0.41
267.77%
-0.33
19.93%
graham net net
0.29
-
0.67
128.20%
2.86
325.24%
1.38
51.65%
2.29
65.85%
2.28
0.67%
1.56
31.45%
1.42
8.80%
0.55
61.08%
graham number
0.84
-
2.48
194.69%
8.69
250.95%
8.57
1.40%
9.63
12.35%
9.83
2.05%
8.15
17.04%
7.84
3.90%
4.50
42.61%
income quality
0.86
-
0.78
9.32%
0.52
32.67%
0.68
29.12%
0.84
23.86%
0.73
13.54%
0.88
21.21%
0.79
10.33%
0.79
0.12%
intangibles to total assets
0
-
0
0.00
Infinity%
0
100%
0
0
0
0
0
interest coverage
-74.56
-
-41.76
43.99%
interest debt per share
0.12
-
0.26
-
0.25
5.27%
0.32
29.00%
0.56
74.85%
0.28
50.29%
inventory turnover
invested capital
0.04
-
0.11
-
0.09
14.71%
0.15
69.50%
0.29
91.58%
0.31
5.75%
market cap
240.05M
-
240.05M
0%
240.05M
0%
94.63M
60.58%
349.92M
269.77%
358.89M
2.57%
353.84M
1.41%
101.60M
71.29%
120.79M
18.89%
net current asset value
6.13M
-
14.03M
128.93%
59.72M
325.52%
29.22M
51.07%
44.00M
50.60%
66.91M
52.04%
50.56M
24.43%
51.59M
2.03%
27.01M
47.64%
net debt to ebitda
3.40
-
2.00
41.12%
2.68
33.64%
0.55
79.50%
1.05
90.94%
1.54
47.06%
1.24
19.29%
0.64
48.80%
0.70
9.48%
net income per share
-0.09
-
-0.37
297.06%
-1.13
203.38%
-1.94
71.99%
-1.66
14.00%
-1.56
6.24%
-1.41
9.58%
-1.48
4.92%
-1.11
25.13%
operating cash flow per share
-0.08
-
-0.29
260.07%
-0.59
104.27%
-1.31
122.08%
-1.40
6.51%
-1.13
18.93%
-1.24
9.60%
-1.17
5.53%
-0.87
25.52%
payables turnover
0.98
-
receivables turnover
4.58
-
2.23
51.42%
4.75
113.66%
21.75
357.45%
3.23
85.13%
research and ddevelopement to revenue
24.98
-
7.95
68.18%
10.63
33.79%
2.77
73.98%
30.98
1,019.54%
7.34
76.32%
return on tangible assets
-0.26
-
-0.47
78.42%
-0.35
26.04%
-0.86
146.98%
-0.51
40.36%
-0.45
12.21%
-0.53
17.68%
-0.58
9.23%
-0.82
42.56%
revenue per share
0.06
-
0.16
176.45%
0.11
29.92%
0.48
334.36%
0.03
92.69%
0.12
243.51%
roe
-0.28
-
-0.50
81.55%
-0.38
25.27%
-1.15
204.26%
-0.67
41.41%
-0.57
15.59%
-0.67
18.81%
-0.80
19.21%
-1.37
70.19%
roic
-0.28
-
-0.50
81.55%
-0.36
28.19%
-1.16
221.10%
-0.56
51.71%
-0.49
13.60%
-0.52
6.38%
-0.56
8.83%
-1.00
78.65%
sales general and administrative to revenue
9.89
-
3.68
62.73%
4.64
26.07%
1.16
75.06%
12.98
1,020.99%
shareholders equity per share
0.34
-
0.74
118.71%
2.98
305.99%
1.69
43.47%
2.48
46.77%
2.75
11.07%
2.09
23.89%
1.84
11.99%
0.81
56.01%
stock based compensation to revenue
6.28
-
1.89
69.96%
3.32
76.20%
0.77
76.80%
7.63
889.44%
tangible asset value
6.94M
-
15.17M
118.71%
61.43M
304.83%
33.97M
44.70%
54.58M
60.68%
78.91M
44.57%
65.49M
17.01%
65.68M
0.29%
37.09M
43.54%
tangible book value per share
0.34
-
0.74
118.71%
2.98
304.83%
1.69
43.31%
2.48
46.77%
2.75
11.07%
2.09
23.89%
1.84
11.99%
0.81
56.01%
working capital
6.16M
-
14.07M
128.25%
59.72M
324.42%
34.39M
42.41%
49.37M
43.54%
71.21M
44.24%
55.68M
21.81%
65.64M
17.89%
34.37M
47.63%

All numbers in USD (except ratios and percentages)